Maged Shenouda

Insider Reports History

Location
New York, NY
Signature
/s/ Maged Shenouda
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maged Shenouda:

Company Role Class Num Shares Value Price $ Report Date Ownership
RELMADA THERAPEUTICS, INC. Chief Financial Officer Common Stock 800,000 $3,296,000 $4.12 15 Dec 2025 Direct
RELMADA THERAPEUTICS, INC. Chief Financial Officer Stock Appreciation Rights 828,000 12 Dec 2025 Direct
RELMADA THERAPEUTICS, INC. Chief Financial Officer Stock Option (right to buy) 600,000 26 Jun 2025 Direct

Insider Reports Filed by Maged Shenouda

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RLMD RELMADA THERAPEUTICS, INC. 12 Dec 2025 2 +$48,060 4 Chief Financial Officer 16 Dec 2025, 09:30
RLMD RELMADA THERAPEUTICS, INC. 05 Nov 2025 1 +$1,100,000 4 Chief Financial Officer 06 Nov 2025, 07:30
RLMD RELMADA THERAPEUTICS, INC. 26 Jun 2025 1 $0 4 Chief Financial Officer 30 Jun 2025, 19:29
RLMD RELMADA THERAPEUTICS, INC. 16 May 2025 3 +$97,208 4 Chief Financial Officer 20 May 2025, 18:03
RLMD RELMADA THERAPEUTICS, INC. 09 Sep 2024 3 +$149,701 4 Chief Financial Officer 11 Sep 2024, 17:46
RLMD RELMADA THERAPEUTICS, INC. 24 May 2024 2 $0 4 Chief Financial Officer 29 May 2024, 21:24
RLMD RELMADA THERAPEUTICS, INC. 29 Jan 2024 3 +$125,717 4 Chief Financial Officer 31 Jan 2024, 18:28
RLMD RELMADA THERAPEUTICS, INC. 15 Dec 2023 1 $0 4 Chief Financial Officer 19 Dec 2023, 17:28
RLMD RELMADA THERAPEUTICS, INC. 25 May 2023 1 $0 4 Chief Financial Officer 30 May 2023, 17:09
RLMD RELMADA THERAPEUTICS, INC. 16 Dec 2022 1 $0 4 CFO 20 Dec 2022, 18:31
RLMD RELMADA THERAPEUTICS, INC. 16 Dec 2022 1 $0 4 Chief Financial Officer 20 Dec 2022, 16:34
RLMD RELMADA THERAPEUTICS, INC. 25 May 2022 2 $0 4 Chief Financial Officer 26 May 2022, 18:42
RLMD RELMADA THERAPEUTICS, INC. 17 Dec 2021 1 $0 4 Chief Financial Officer 21 Dec 2021, 20:30